{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:25:30Z","timestamp":1773271530485,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2001,11,1]],"date-time":"2001-11-01T00:00:00Z","timestamp":1004572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1006\/pmed.2001.0917","type":"journal-article","created":{"date-parts":[[2002,9,18]],"date-time":"2002-09-18T20:38:41Z","timestamp":1032381521000},"page":"470-475","source":"Crossref","is-referenced-by-count":72,"title":["Sociodemographic Characteristics Associated with Medical Appointment Adherence among HIV-Seropositive Patients Seeking Treatment in a County Outpatient Facility"],"prefix":"10.1006","volume":"33","author":[{"given":"Dennis","family":"Israelski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Gore-Felton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Power","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jane","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Koopman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/pmed.2001.0917_RF1","first-page":"3","volume":"11","year":"1999","journal-title":"HIV\/AIDS Surveill Rep"},{"key":"10.1006\/pmed.2001.0917_RF2","first-page":"3","volume":"5","year":"1999","journal-title":"HIV Surveill Supp Rep"},{"key":"10.1006\/pmed.2001.0917_RF3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJM199604183341602","article-title":"Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine","volume":"334","author":"Collier","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1006\/pmed.2001.0917_RF4","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1056\/NEJM199512073332303","article-title":"A short-term study of the safety, pharmacokinetics, and efficacy of ritonavir, an inhibitor of HIV-1 protease. European-Australian collaborative ritonavir study group","volume":"333","author":"Danner","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1006\/pmed.2001.0917_RF5","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJM199709113371102","article-title":"Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy","volume":"337","author":"Gulick","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1006\/pmed.2001.0917_RF6","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1086\/515312","article-title":"A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HI)-1 protease, to treat HIV infection","volume":"177","author":"Markowitz","year":"1998","journal-title":"J Infect Dis."},{"key":"10.1006\/pmed.2001.0917_RF7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/j.1552-4604.1998.tb04814.x","article-title":"Safety, pharmacokinetics, and antiretroviral activity of the potent, specific human immunodeficiency virus protease inhibitor nelfinavir: results of a phase I\/II trial and extended follow-up in patients infected with human immunodeficiency virus","volume":"38","author":"Moyle","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1006\/pmed.2001.0917_RF8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/archpsyc.1997.01830230091013","article-title":"A \u201csecond life\u201d agenda: psychiatric research issues raised by protease inhibitor treatments for people with the human immunodeficiency virus or the acquired immunodeficiency syndrome","volume":"54","author":"Rabkin","year":"1997","journal-title":"Arch Gen Psych"},{"key":"10.1006\/pmed.2001.0917_RF9","first-page":"91","article-title":"How to detect and manage low patient compliance in chronic illness","volume":"35","author":"Haynes","year":"1980","journal-title":"Geriatrics"},{"key":"10.1006\/pmed.2001.0917_RF10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/21548331.1996.11443331","article-title":"New strategies to combat HIV drug resistance","volume":"15","author":"Richman","year":"1996","journal-title":"Hospital Practice"},{"key":"10.1006\/pmed.2001.0917_RF11","first-page":"871","article-title":"Human immunodeficiency virus and AIDS","author":"Bialer","year":"2000"},{"key":"10.1006\/pmed.2001.0917_RF12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1037\/0278-6133.17.4.310","article-title":"Implications of HIV treatment advances for behavioral research on AIDS: protease inhibitors and new challenges in HIV secondary prevention","volume":"17","author":"Kelly","year":"1998","journal-title":"Health Psychol."},{"key":"10.1006\/pmed.2001.0917_RF13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1207\/s15327558ijbm0101_6","article-title":"Distress, denial, and low adherence to behavioral interventions predict faster disease progression in gay men infected with human immunodeficiency virus","volume":"1","author":"Ironson","year":"1994","journal-title":"Int J Behav Med"},{"key":"10.1006\/pmed.2001.0917_RF14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042560-199806010-00003","article-title":"Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease","volume":"18","author":"Eldred","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1006\/pmed.2001.0917_RF15","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/09540129650125696","article-title":"Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance","volume":"8","author":"Singh","year":"1996","journal-title":"AIDS Care"},{"key":"10.1006\/pmed.2001.0917_RF16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.7326\/0003-4819-129-6-199809150-00015","article-title":"The era of adherence to HIV therapy","volume":"129","author":"Altice","year":"1998","journal-title":"Ann Int Med"},{"key":"10.1006\/pmed.2001.0917_RF17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1055-3290(97)80012-X","article-title":"Compliance\/adherence and care management in HIV disease","volume":"8","author":"Crespo-Fierro","year":"1997","journal-title":"J Assoc Nurses AIDS Care"},{"key":"10.1006\/pmed.2001.0917_RF18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/apc.1999.13.185","article-title":"Predictors of self-reported adherence in persons living with HIV disease","volume":"13","author":"Holzemer","year":"1999","journal-title":"AIDS Patient Care STDs"},{"key":"10.1006\/pmed.2001.0917_RF19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/09540129947983","article-title":"Predictors of outpatient medical appointment attendance among persons with HIV","volume":"11","author":"Catz","year":"1999","journal-title":"AIDS Care"},{"key":"10.1006\/pmed.2001.0917_RF20","first-page":"19","article-title":"Compliance with public sector HIV medical care","volume":"87","author":"Kissinger","year":"1995","journal-title":"J Nat Med Assoc"},{"key":"10.1006\/pmed.2001.0917_RF21","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1001\/jama.1992.03480130129038","article-title":"An overview of interventions to improve compliance with appointment keeping for medical services","volume":"267","author":"Macharia","year":"1992","journal-title":"J Am Med Assoc"},{"key":"10.1006\/pmed.2001.0917_RF22","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1097\/00005650-199808000-00004","article-title":"Effectiveness of interventions to improve patient compliance: a meta-analysis","volume":"36","author":"Roter","year":"1998","journal-title":"Med Care"},{"key":"10.1006\/pmed.2001.0917_RF23","series-title":"Statistical power analysis for the behavioral sciences","author":"Cohen","year":"1988"},{"key":"10.1006\/pmed.2001.0917_RF24","unstructured":"Centers for Disease Control and Prevention, A glance at the HIV epidemic. CDC Update December 1999."},{"key":"10.1006\/pmed.2001.0917_RF25","first-page":"1","volume":"38","year":"1989","journal-title":"MMWR"},{"key":"10.1006\/pmed.2001.0917_RF26","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.2105\/AJPH.81.10.1285","article-title":"Utilization of health services in a cohort of intravenous drug users with known HIV-1 serostatus","volume":"81","author":"Solomon","year":"1991","journal-title":"Am J Pub Health"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174350190917X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174350190917X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T11:54:37Z","timestamp":1557316477000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009174350190917X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,11]]}},"alternative-id":["S009174350190917X"],"URL":"https:\/\/doi.org\/10.1006\/pmed.2001.0917","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}